Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study

Tumor necrosis factor inhibitor (TNFi) therapies are often the first biologic therapy used to treat rheumatoid arthritis (RA) patients. However, a substantial fraction of patients do not respond adequately to TNFi therapies. A test with the ability to predict response would inform therapeutic decisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappas, Dimitrios A., Brittle, Christine, Mossell, James E., Withers, Johanna B., Lim-Harashima, Jeraldine, Kremer, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703510/
https://www.ncbi.nlm.nih.gov/pubmed/33258003
http://dx.doi.org/10.1007/s00296-020-04746-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703510/
https://www.ncbi.nlm.nih.gov/pubmed/33258003
http://dx.doi.org/10.1007/s00296-020-04746-7

Ejemplares similares